These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34828342)

  • 21. Alu element insertion in the MLH1 exon 6 coding sequence as a mutation predisposing to Lynch syndrome.
    Solassol J; Larrieux M; Leclerc J; Ducros V; Corsini C; Chiésa J; Pujol P; Rey JM
    Hum Mutat; 2019 Jun; 40(6):716-720. PubMed ID: 30815977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ
    Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients.
    Jarhelle E; Riise Stensland HMF; Hansen GÅM; Skarsfjord S; Jonsrud C; Ingebrigtsen M; Strømsvik N; Van Ghelue M
    Sci Rep; 2019 Dec; 9(1):19986. PubMed ID: 31882575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors.
    Ryu JM; Nam SJ; Kim SW; Lee JE; Chae BJ; Lee SK; Yu J
    Jpn J Clin Oncol; 2020 Feb; 50(2):104-113. PubMed ID: 31926487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome.
    Concolino P; Rizza R; Hackmann K; Minucci A; Scaglione GL; De Bonis M; Costella A; Zuppi C; Schrock E; Capoluongo E
    Mol Diagn Ther; 2017 Oct; 21(5):539-545. PubMed ID: 28620890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of three alternative transcripts of the BRCA1 gene in patients with breast cancer and a family history of breast and/or ovarian cancer who tested negative for pathogenic mutations.
    Gambino G; Tancredi M; Falaschi E; Aretini P; Caligo MA
    Int J Mol Med; 2015 Apr; 35(4):950-6. PubMed ID: 25683334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing.
    Kluska A; Balabas A; Paziewska A; Kulecka M; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2015 May; 8():19. PubMed ID: 25948282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil.
    Cipriano NM; de Brito AM; de Oliveira ES; de Faria FC; Lemos S; Rodrigues AN; de Oliveira Lopes D; Dos Santos LL
    Breast Cancer; 2019 May; 26(3):397-405. PubMed ID: 30535581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.
    Cao WM; Zheng YB; Gao Y; Ding XW; Sun Y; Huang Y; Lou CJ; Pan ZW; Peng G; Wang XJ
    BMC Cancer; 2019 Jun; 19(1):551. PubMed ID: 31174498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
    Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
    BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenicity reclassification of two BRCA1/BRCA2 exonic duplications after identification of genomic breakpoints and tandem orientation.
    Pinheiro M; Peixoto A; Santos C; Escudeiro C; Bizarro S; Pinto P; Santos R; Pinto C; Guerra J; Silva J; Teixeira MR
    Cancer Genet; 2020 Oct; 248-249():18-24. PubMed ID: 32971473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Molecular Characterization of the Allelic Expression of the
    Dominguez-Ortiz J; Álvarez-Gómez RM; Montiel-Manríquez R; Cedro-Tanda A; Alcaraz N; Castro-Hernández C; Bautista-Hinojosa L; Contreras-Espinosa L; Torres-Maldonado L; Fragoso-Ontiveros V; Sánchez-Contreras Y; González-Barrios R; Fuente-Hernández MA; Mejía-Aguayo ML; Juárez-Figueroa U; Padua-Bracho A; Sosa-León R; Obregon-Serrano G; Vidal-Millán S; Núñez-Martínez PM; Pedroza-Torres A; Nicasio-Arzeta S; Rodríguez A; Luna F; Cisneros-Soberanis F; Frías S; Arriaga-Canon C; Herrera-Montalvo LA
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
    Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
    J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.
    Yang C; Arnold AG; Trottier M; Sonoda Y; Abu-Rustum NR; Zivanovic O; Robson ME; Stadler ZK; Walsh MF; Hyman DM; Offit K; Zhang L
    Breast Cancer Res Treat; 2016 Dec; 160(3):447-456. PubMed ID: 27757719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel.
    Kwong A; Shin VY; Au CH; Law FB; Ho DN; Ip BK; Wong AT; Lau SS; To RM; Choy G; Ford JM; Ma ES; Chan TL
    J Mol Diagn; 2016 Jul; 18(4):580-94. PubMed ID: 27157322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The
    Arason A; Agnarsson BA; Johannesdottir G; Johannsson OT; Hilmarsdottir B; Reynisdottir I; Barkardottir RB
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
    Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
    PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of BRCA1 large genomic rearrangements to early-onset and familial breast/ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Amin A; Loya A; Hamann U
    Breast Cancer Res Treat; 2017 Jan; 161(2):191-201. PubMed ID: 27826754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.